These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20037964)

  • 1. Evaluation of the efficacy of a canine influenza virus (H3N8) vaccine in dogs following experimental challenge.
    Deshpande MS; Jirjis FF; Tubbs AL; Jayappa H; Sweeney D; Spencer SJ; Lakshmanan N; Wasmoen TL
    Vet Ther; 2009; 10(3):103-12. PubMed ID: 20037964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental reproduction of canine influenza virus H3N8 infection in young puppies.
    Deshpande M; Abdelmagid O; Tubbs A; Jayappa H; Wasmoen T
    Vet Ther; 2009; 10(1-2):29-39. PubMed ID: 19742446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy and immunogenicity of an inactivated avian-origin H3N2 canine influenza vaccine in dogs challenged with the virulent virus.
    Lee C; Jung K; Oh J; Oh T; Han S; Hwang J; Yeom M; Son D; Kim J; Park B; Moon H; Song D; Kang B
    Vet Microbiol; 2010 Jul; 143(2-4):184-8. PubMed ID: 20034748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs.
    Karaca K; Dubovi EJ; Siger L; Robles A; Audonnet JC; Jiansheng Y; Nordgren R; Minke JM
    Am J Vet Res; 2007 Feb; 68(2):208-12. PubMed ID: 17269888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of canine influenza virus (H3N8) among susceptible dogs.
    Jirjis FF; Deshpande MS; Tubbs AL; Jayappa H; Lakshmanan N; Wasmoen TL
    Vet Microbiol; 2010 Aug; 144(3-4):303-9. PubMed ID: 20347235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
    Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.
    Nogales A; Rodriguez L; Chauché C; Huang K; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martínez-Sobrido L
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and exposure factors for seropositivity to H3N8 canine influenza virus in dogs with influenza-like illness in the United States.
    Anderson TC; Crawford PC; Dubovi EJ; Gibbs EP; Hernandez JA
    J Am Vet Med Assoc; 2013 Jan; 242(2):209-16. PubMed ID: 23276098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells.
    Quintana AM; Hussey SB; Burr EC; Pecoraro HL; Annis KM; Rao S; Landolt GA
    Am J Vet Res; 2011 Aug; 72(8):1071-8. PubMed ID: 21801065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
    Lee JH; Gramer MR; Joo HS
    Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.